Screening of Drug Repositioning Candidates for Castration Resistant Prostate Cancer

Purpose: Most prostate cancers (PCs) initially respond to androgen deprivation therapy (ADT), but eventually many PC patients develop castration resistant PC (CRPC). Currently, available drugs that have been approved for the treatment of CRPC patients are limited. Computational drug repositioning me...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, In-Wha, Kim, Jae Hyun, Oh, Jung Mi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664029/
https://www.ncbi.nlm.nih.gov/pubmed/31396486
http://dx.doi.org/10.3389/fonc.2019.00661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664029/
https://www.ncbi.nlm.nih.gov/pubmed/31396486
http://dx.doi.org/10.3389/fonc.2019.00661

Ejemplares similares